Darvadstrocel (Alofisel) – indicated for the treatment of complex perianal fistulas caused by Crohn's disease – is the first allogeneic stem‐cell therapy to be approved in the EU. This article examines its administration, efficacy and place in therapy.
CITATION STYLE
Chaplin, S. (2019). Darvadstrocel for the treatment of complex perianal fistulas. Prescriber, 30(11), 32–33. https://doi.org/10.1002/psb.1804
Mendeley helps you to discover research relevant for your work.